EXPERIMENTAL TYPE III PNEUMOCOCCUS PNEUMONIA IN MONKEYS : I. PRODUCTION AND CLINICAL COURSE

T Francis1, E E Terrell

  • 1Hospital of The Rockefeller Institute for Medical Research.

Insights

Researchers created an experimental pneumonia in cynomolgus monkeys using Type III Pneumococcus. This model closely mimics human pneumococcus lobar pneumonia, offering insights into disease progression and outcomes.

Area of Science:

  • * Infectious Diseases
  • * Pulmonology
  • * Veterinary Pathology

Background:

  • * Pneumococcus lobar pneumonia is a significant human respiratory illness.
  • * Animal models are crucial for understanding disease pathogenesis and testing interventions.
  • * Previous models may not fully replicate the clinical and pathological features of human disease.

Purpose of the Study:

  • * To establish and characterize an experimental model of pneumococcus lobar pneumonia in cynomolgus monkeys.
  • * To investigate the clinical and pathological manifestations of induced pneumonia.
  • * To identify potential indicators of disease severity and outcome.

Main Methods:

  • * Intratracheal and intrabronchial inoculation of Type III Pneumococcus in *M. cynomolgos* monkeys.
  • * Clinical observation of disease progression, including fever and general condition.
  • * Pathological examination of pulmonary lesions and assessment of septicemia.

Main Results:

  • * Successfully induced experimental pneumonia resembling human lobar pneumonia.
  • * Observed localized lobar pulmonary lesions, septicemia, and sustained fever.
  • * Noted significant variations in disease severity attributed to individual animal resistance.
  • * Bacteremia levels correlated with disease outcome, serving as a key prognostic indicator.

Conclusions:

  • * The experimental pneumonia model in cynomolgus monkeys accurately reflects key aspects of human pneumococcus lobar pneumonia.
  • * Individual host resistance is a critical factor influencing disease severity.
  • * Septicemia levels provide a valuable objective measure for predicting the outcome of experimental pneumococcal pneumonia.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: